Market closed

Stryker/$SYK

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About Stryker

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Ticker

$SYK

Sector

Health Care

Trading on

NYSE

Industry

Health Care Equipment & Supplies

Headquarters

Portage, United States

Employees

52,000

Website

www.stryker.com

Stryker Metrics

BasicAdvanced

$138B

38.70 $9.33

0.92 $3.20

0.93%

Price and volume

Market cap

$138B

Beta

0.92

52-week high

$389.03

52-week low

$307.23

Average daily volume

1.2M

Dividend rate

$3.20

Financial strength

Current ratio

1.913

Quick ratio

1.098

Long term debt to equity

67.988

Total debt to equity

79.443

Dividend payout ratio (TTM)

33.40%

Interest coverage (TTM)

13.08%

Management effectiveness

Return on assets (TTM)

7.13%

Return on equity (TTM)

18.87%

Valuation

Price to earnings (TTM)

38.702

Price to revenue (TTM)

6.253

Price to book

6.83

Price to tangible book (TTM)

-115.9

Price to free cash flow (TTM)

42.873

Dividend yield (TTM)

0.89%

Forward dividend yield

0.93%

Growth

Revenue change (TTM)

10.51%

Earnings per share change (TTM)

38.37%

3-year revenue growth (CAGR)

9.65%

3-year earnings per share growth (CAGR)

23.36%

3-year dividend per share growth (CAGR)

8.29%

What the Analysts think about Stryker

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Stryker stock.

Stryker Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

Stryker Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Stryker News

AllArticlesVideos

INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI

Business Wire·1 week ago

Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment

GlobeNewsWire·1 week ago

Exclusive: Medical device maker Stryker nearing a deal to buy Inari Medical, sources say

Reuters·1 week ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SYK

$

Capital at risk

Market closed

Upcoming events

Jan31

Stryker

Dividend·Payment

$0.84

Per share

FAQs

What’s the current market cap for Stryker stock?

Stryker (SYK) has a market cap of $138B as of January 15, 2025.

What is the P/E ratio for Stryker stock?

The price to earnings (P/E) ratio for Stryker (SYK) stock is 38.7 as of January 15, 2025.

Does Stryker stock pay dividends?

Yes, the Stryker (SYK) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is $3.2 and the yield is 0.93%. Stryker has a payout ratio of 33.4% on a trailing twelve-month basis.

When is the next Stryker dividend payment date?

The next Stryker (SYK) dividend payment is scheduled for January 31, 2025.

What is the beta indicator for Stryker?

Stryker (SYK) has a beta rating of 0.92. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.